Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Ivy Riano is a thoracic oncologist at Dartmouth Cancer Center, and Assistant Professor at Dartmouth Cancer Center, affiliated to Geisel School of Medicine at Dartmouth. Her career goal is to become an independent clinician-scientist focused on thoracic malignancies to improve the care of patients with cancer. Her clinical and research interests focused on the development of innovative therapeutic strategies and clinical trials to treat patients with lung cancer through molecularly targeted therapies and immunotherapies.

Program: Patient Education Ambassadors 2023-24
The 2023-2024 GRACE Patient Education Ambassadors discuss topics in a variety of cancers, from screening and treating prostate cancer to aiding in the cost of cancer treatment.
Author
Ivy Riano Monsalve, MD - Guest Faculty
Image
Patient Education Ambassadors 2023-24

La Dra. Ivy Riano analiza las diversas opciones de tratamiento para pacientes con cáncer y analiza las diversas opciones de tratamiento para pacientes con cáncer.

Para ver la lista completa de videos da click aquí.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on